MannKind Announces CFO Transition
| DVAX Stock | USD 12.36 0.19 1.56% |
Slightly above 67 percent of all Dynavax Technologies' investors are curious in acquiring. The analysis of the overall investor sentiment regarding Dynavax Technologies suggests that a large number of traders are confidant. Dynavax Technologies' investing sentiment can be driven by a variety of factors including economic data, Dynavax Technologies' earnings reports, geopolitical events, and overall market trends.
Dynavax |
Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through December 31, 2024Christopher Prentiss appointed Chief Financial Officer,
Read at benzinga.com
 |
Dynavax Technologies Current Investor Sentiment
Panic Vs Confidence
67
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Dynavax Technologies' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Dynavax Technologies.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
Dynavax Technologies Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Dynavax Technologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Dynavax Technologies Fundamental Analysis
We analyze Dynavax Technologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dynavax Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dynavax Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Dynavax Technologies is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Dynavax Technologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dynavax Technologies stock to make a market-neutral strategy. Peer analysis of Dynavax Technologies could also be used in its relative valuation, which is a method of valuing Dynavax Technologies by comparing valuation metrics with similar companies.
Peers
Dynavax Technologies Related Equities
| EBS | Emergent Biosolutions | 5.86 | ||||
| PCRX | Pacira BioSciences, | 2.06 | ||||
| NBIX | Neurocrine Biosciences | 1.39 | ||||
| ANIP | ANI Pharmaceuticals | 1.38 | ||||
| COLL | Collegium Pharmaceutical | 1.37 | ||||
| AMPH | Amphastar | 1.08 | ||||
| LNTH | Lantheus Holdings | 1.01 | ||||
| ITCI | Intracellular | 0.22 | ||||
| ALKS | Alkermes Plc | 0.75 | ||||
| DRRX | Durect | 4.44 | ||||
| AQST | Aquestive Therapeutics | 4.85 | ||||
| IRWD | Ironwood Pharmaceuticals | 5.11 |
Additional Tools for Dynavax Stock Analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.